WallStreetZenWallStreetZen

NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

Analyst price target for QNRX

Based on 1 analyst offering 12 month price targets for Quoin Pharmaceuticals Ltd.
Min Forecast
$4.00+509.76%
Avg Forecast
$4.00+509.76%
Max Forecast
$4.00+509.76%

Should I buy or sell QNRX stock?

Based on 1 analyst offering ratings for Quoin Pharmaceuticals Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their QNRX stock forecasts and price targets.

QNRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is QNRX forecast to generate an efficient return?
Company
-21.81%
Industry
47.27%
Market
33.29%
QNRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is QNRX forecast to generate an efficient return on assets?
Company
-12.34%
Industry
13.28%
QNRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QNRX earnings per share forecast

What is QNRX's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$3.52
Avg 2 year Forecast
-$0.50

QNRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QNRX$0.66$4.00+509.76%Strong Buy
CING$0.43N/AN/A
PHIO$5.05$36.00+612.87%Buy
FRES$2.96N/AN/A
ADTX$1.61N/AN/A

Quoin Pharmaceuticals Stock Forecast FAQ

Is Quoin Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: QNRX) stock is to Strong Buy QNRX stock.

Out of 1 analyst, 1 (100%) are recommending QNRX as a Strong Buy, 0 (0%) are recommending QNRX as a Buy, 0 (0%) are recommending QNRX as a Hold, 0 (0%) are recommending QNRX as a Sell, and 0 (0%) are recommending QNRX as a Strong Sell.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is QNRX's earnings growth forecast for 2024-2025?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 20.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.88%.

Quoin Pharmaceuticals's earnings in 2024 is -$8,410,784.On average, 2 Wall Street analysts forecast QNRX's earnings for 2024 to be -$13,989,595, with the lowest QNRX earnings forecast at -$16,875,073, and the highest QNRX earnings forecast at -$11,104,116.

In 2025, QNRX is forecast to generate -$1,989,985 in earnings, with the lowest earnings forecast at -$1,989,985 and the highest earnings forecast at -$1,989,985.

What is QNRX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: QNRX) forecast ROE is -21.81%, which is considered weak.

What is QNRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year QNRX price target, the average QNRX price target is $4.00, with the highest QNRX stock price forecast at $4.00 and the lowest QNRX stock price forecast at $4.00.

The Wall Street analyst predicted that Quoin Pharmaceuticals's share price could reach $4.00 by Mar 15, 2025. The average Quoin Pharmaceuticals stock price prediction forecasts a potential upside of 509.76% from the current QNRX share price of $0.66.

What is QNRX's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that QNRX's EPS will be -$3.52 for 2024, with the lowest EPS forecast at -$4.24, and the highest EPS forecast at -$2.79. In 2025, QNRX's EPS is forecast to hit -$0.50 (min: -$0.50, max: -$0.50).

What is QNRX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: QNRX) forecast ROA is -12.34%, which is lower than the forecast US Biotechnology industry average of 13.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.